267 related articles for article (PubMed ID: 24816953)
1. Health system costs by sex, age and proximity to death, and implications for estimation of future expenditure.
Blakely T; Atkinson J; Kvizhinadze G; Nghiem N; McLeod H; Wilson N
N Z Med J; 2014 May; 127(1393):12-25. PubMed ID: 24816953
[TBL] [Abstract][Full Text] [Related]
2. Updated New Zealand health system cost estimates from health events by sex, age and proximity to death: further improvements in the age of 'big data'.
Blakely T; Atkinson J; Kvizhinadze G; Nghiem N; McLeod H; Davies A; Wilson N
N Z Med J; 2015 Sep; 128(1422):13-23. PubMed ID: 26411843
[TBL] [Abstract][Full Text] [Related]
3. The impact of population ageing on future Danish drug expenditure.
Kildemoes HW; Christiansen T; Gyrd-Hansen D; Kristiansen IS; Andersen M
Health Policy; 2006 Feb; 75(3):298-311. PubMed ID: 16399170
[TBL] [Abstract][Full Text] [Related]
4. The cost of in-patient care in Western Australia in the last years of life: a population-based data linkage study.
Moorin RE; Holman CD
Health Policy; 2008 Mar; 85(3):380-90. PubMed ID: 17913279
[TBL] [Abstract][Full Text] [Related]
5. [Reimbursed health expenditures during the last year of life, in France, in the year 2008].
Ricci P; Mezzarobba M; Blotière PO; Polton D
Rev Epidemiol Sante Publique; 2013 Feb; 61(1):29-36. PubMed ID: 23318018
[TBL] [Abstract][Full Text] [Related]
6. Time to death and health expenditure: an improved model for the impact of demographic change on health care costs.
Seshamani M; Gray A
Age Ageing; 2004 Nov; 33(6):556-61. PubMed ID: 15308460
[TBL] [Abstract][Full Text] [Related]
7. The importance of proximity to death in modelling community medication expenditures for older people: evidence from New Zealand.
Moore PV; Bennett K; Normand C
Appl Health Econ Health Policy; 2014 Dec; 12(6):623-33. PubMed ID: 25141830
[TBL] [Abstract][Full Text] [Related]
8. Health care costs in the last year of life--the Dutch experience.
Polder JJ; Barendregt JJ; van Oers H
Soc Sci Med; 2006 Oct; 63(7):1720-31. PubMed ID: 16781037
[TBL] [Abstract][Full Text] [Related]
9. Patterns of cancer care costs in a country with detailed individual data.
Blakely T; Atkinson J; Kvizhinadze G; Wilson N; Davies A; Clarke P
Med Care; 2015 Apr; 53(4):302-9. PubMed ID: 25749656
[TBL] [Abstract][Full Text] [Related]
10. Cost of treating seriously mentally ill persons with HIV following highly active retroviral therapy (HAART).
Rothbard AB; Lee S; Blank MB
J Ment Health Policy Econ; 2009 Dec; 12(4):187-94. PubMed ID: 20195006
[TBL] [Abstract][Full Text] [Related]
11. Life expectancy and health care expenditures: a new calculation for Germany using the costs of dying.
Breyer F; Felder S
Health Policy; 2006 Jan; 75(2):178-86. PubMed ID: 15893848
[TBL] [Abstract][Full Text] [Related]
12. The effect of revised populations on mortality statistics for the United States, 2000.
Anderson RN; Arias E
Natl Vital Stat Rep; 2003 Jun; 51(9):1-24. PubMed ID: 12795490
[TBL] [Abstract][Full Text] [Related]
13. [Real per capita health spending by age and sex in Spain (1998-2008): changes and effects on public healthcare expenditure projections].
Blanco Moreno Á; Urbanos Garrido R; Thuissard Vasallo IJ
Gac Sanit; 2013; 27(3):220-5. PubMed ID: 23140979
[TBL] [Abstract][Full Text] [Related]
14. Public healthcare expenditure in Spain: measuring the impact of driving factors.
Blanco-Moreno Á; Urbanos-Garrido RM; Thuissard-Vasallo IJ
Health Policy; 2013 Jun; 111(1):34-42. PubMed ID: 23597871
[TBL] [Abstract][Full Text] [Related]
15. Health system costs for individual and comorbid noncommunicable diseases: An analysis of publicly funded health events from New Zealand.
Blakely T; Kvizhinadze G; Atkinson J; Dieleman J; Clarke P
PLoS Med; 2019 Jan; 16(1):e1002716. PubMed ID: 30620729
[TBL] [Abstract][Full Text] [Related]
16. Short-term persistence of high health care costs in a nationally representative sample of children.
Liptak GS; Shone LP; Auinger P; Dick AW; Ryan SA; Szilagyi PG
Pediatrics; 2006 Oct; 118(4):e1001-9. PubMed ID: 17015496
[TBL] [Abstract][Full Text] [Related]
17. Cigarette smoking and lifetime medical expenditures.
Hodgson TA
Milbank Q; 1992; 70(1):81-125. PubMed ID: 1588892
[TBL] [Abstract][Full Text] [Related]
18. Projecting health-care expenditure for Switzerland: further evidence against the 'red-herring' hypothesis.
Colombier C; Weber W
Int J Health Plann Manage; 2011; 26(3):246-63. PubMed ID: 20939027
[TBL] [Abstract][Full Text] [Related]
19. Does universal comprehensive insurance encourage unnecessary use? Evidence from Manitoba says "no".
Roos NP; Forget E; Walld R; MacWilliam L
CMAJ; 2004 Jan; 170(2):209-14. PubMed ID: 14734434
[TBL] [Abstract][Full Text] [Related]
20. The economic burden of prostate cancer, California, 1998.
Max W; Rice DP; Sung HY; Michel M; Breuer W; Zhang X
Cancer; 2002 Jun; 94(11):2906-13. PubMed ID: 12115378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
